根据提供的文献内容，我将按照要求提取并标准化信息，最终以JSON格式呈现。以下是详细的提取和标准化过程：

### 文献摘要
该文献主要研究了α-突触核蛋白（α-synuclein, aS）的野生型和A30P突变体形成的淀粉样纤维的结构特征，并通过氢氘交换结合核磁共振（NMR）光谱学进行分析。研究表明，A30P突变并未改变aS淀粉样纤维中β-折叠的数量、位置和整体排列。

### 提取和标准化的信息

#### 1. 变异信息
文献中提到的基因和变异为：
- **基因**：α-synuclein (SNCA)
- **变异**：A30P

我们使用HGVS标准命名法对变异进行标准化，具体如下：
- **HGVS**：NM_000345.4:c.89C>C (p.Ala30Pro)

#### 2. 疾病描述
文献中研究的疾病是帕金森病（Parkinson's Disease），对应MONDO数据库中的术语为：
- **疾病名称**：Parkinson's disease
- **MONDO术语编号**：MONDO:0005067

#### 3. 实验方法
文献中提到了以下实验方法：
- **氢氘交换结合NMR光谱学**
- **高分辨率魔角旋转（HR-MAS）NMR光谱学**

详细信息如下：

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.89C>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "C",
                        "alt": "C",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutation"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005067"
    },
    "Experiment Method": [
        {
            "Assay Method": "Hydrogen/Deuterium Exchange Coupled to NMR Spectroscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "15N isotope labeled recombinant wt and A30P aS",
                "Description": "15N isotope labeled recombinant wt and A30P aS were expressed and purified from E. Coli."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89C>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "The A30P mutation does not cause changes in the number, location and overall arrangement of β-strands in amyloid fibrils of aS."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "High-Resolution Magic Angle Spinning (HR-MAS) NMR Spectroscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "15N isotope labeled recombinant wt and A30P aS",
                "Description": "15N isotope labeled recombinant wt and A30P aS were expressed and purified from E. Coli."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89C>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "The A30P mutation does not cause changes in the number, location and overall arrangement of β-strands in amyloid fibrils of aS."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明
1. **变异信息**：提取了文献中提到的α-synuclein基因的A30P突变，并使用HGVS标准命名法进行了标准化。
2. **疾病描述**：确定了文献中研究的疾病为帕金森病，并从MONDO数据库中获取了对应的术语编号。
3. **实验方法**：列出了文献中提到的两种实验方法（氢氘交换结合NMR光谱学和HR-MAS NMR光谱学），并提取了每种方法的详细信息。对于未在文献中明确提及的内容，使用"N.D."表示。

此JSON格式的信息严格遵循用户提供的模板，并确保数据准确且符合科学文献的标准。